Nordea Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-131,300	Closed	-$8.39M	–	866
2025 Q3	$8.39M	Buy	131,300 +3,800	+3%	+$218K	0.01%	482
2025 Q2	$6.25M	Buy	127,500 +900	+0.7%	+$34.8K	0.01%	522
2025 Q1	$4.31M	Buy	126,600 +1,200	+1%	+$50.9K	﹤0.01%	565
2024 Q4	$4.91M	Buy	125,400 +5,300	+4%	+$250K	0.01%	540
2024 Q3	$5.66M	Sell	120,100 -6,800	-5%	-$345K	0.01%	508
2024 Q2	$6.9M	Sell	126,900 -21,800	-15%	-$1.26M	0.01%	467
2024 Q1	$10.3M	Buy	148,700 +43,100	+41%	+$3.09M	0.01%	418
2023 Q4	$6.68M	Sell	105,600 -2,500	-2%	-$138K	0.01%	476
2023 Q3	$5.04M	Buy	108,100 +12,800	+13%	+$661K	0.01%	501
2023 Q2	$5.49M	Sell	95,300 -5,900	-6%	-$335K	0.01%	501
2023 Q1	$4.55M	Sell	101,200 -800	-0.8%	-$38.9K	0.01%	536
2022 Q4	$4.05M	Buy	102,000 +14,100	+16%	+$748K	0.01%	559
2022 Q3	$5.79M	Sell	87,900 -800	-0.9%	-$58K	0.01%	480
2022 Q2	$5.39M	Sell	88,700 -8,300	-9%	-$488K	0.01%	515
2022 Q1	$6.27M	Buy	97,000 +2,900	+3%	+$182K	0.01%	543
2021 Q4	$7.55M	Buy	94,100 +18,500	+24%	+$1.62M	0.01%	486
2021 Q3	$8.5M	Buy	+75,600	New	+$9.49M	0.01%	446